Results 231 to 240 of about 174,743 (266)
Some of the next articles are maybe not open access.

Expression and Influence of Matrix Metalloproteinase–9/Tissue Inhibitor of Metalloproteinase–1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers

International Journal of Lower Extremity Wounds, 2017
Gongchi Li   +7 more
semanticscholar   +1 more source

Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis.

Journal of Crohn's & Colitis, 2016
C. Breynaert   +13 more
semanticscholar   +1 more source

Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition

Journal of Biological Chemistry, 2002
Frank R. Murphy   +7 more
semanticscholar   +1 more source

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

American Journal of Respiratory Cell and Molecular Biology, 2002
R. Russell   +6 more
semanticscholar   +1 more source

Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort

European Journal of Preventive Cardiology, 2017
I. Kormi   +8 more
semanticscholar   +1 more source

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors   +2 more
exaly  

Home - About - Disclaimer - Privacy